USPTO Deadlines
Next Deadline
1214 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2008-11-25)
Due Date
November 25, 2028
Grace Period Ends
May 25, 2029
Application History
50 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 9, 2019 | 8PRT | O | REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED | Loading... |
Jul 9, 2019 | 9G8P | O | REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 | Loading... |
Jul 9, 2019 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
Jul 9, 2019 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
Jul 2, 2019 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
Jun 14, 2019 | PR89 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 | Loading... |
Jun 11, 2019 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
May 22, 2019 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
May 22, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Nov 25, 2017 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
Feb 13, 2017 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Feb 13, 2017 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Feb 7, 2015 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
Feb 7, 2015 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
Feb 7, 2015 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
Jan 26, 2015 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
Nov 25, 2008 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Oct 21, 2008 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Oct 21, 2008 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Oct 21, 2008 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | Loading... |
Oct 20, 2008 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED | Loading... |
Oct 20, 2008 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
Oct 15, 2008 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Oct 10, 2008 | UNDC | O | UNDELIVERABLE MAIL - COURTESY COPY MAILED | Loading... |
Oct 7, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jul 15, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 25, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Jun 9, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Jun 6, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 15, 2008 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
May 9, 2008 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
Apr 30, 2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Apr 30, 2008 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 30, 2008 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 30, 2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Apr 30, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 30, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
Apr 30, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Mar 28, 2008 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Mar 28, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 28, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 28, 2008 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Jan 28, 2008 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Jan 28, 2008 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Dec 31, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 31, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Dec 31, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 2, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 2, 2007 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Nov 2, 2007 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of disorders and diseases of the brain and the nervous system, the eyes, the respiratory tract, the immune system and the skin; [ analgesic, anti-rheumatic, anti-inflammatory, anti-allergic, neurological and cardiovascular medicine; pharmaceutical preparations, namely, antidiabetics; ] pharmaceutical preparations for the treatment of diseases of the central nervous system; [ Pharmaceutical Drugs Containing Chamomile for the Treatment of Disorders of the Skin, Ears, Gums and Mouth, Respiratory, Gastro-Intestinal and Urogenital Systems; pharmaceutical preparations, namely, antibiotics; ] pharmaceutical preparations for the treatment of infections; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of urogenital diseases and disorders; [ sanitary preparations for medical use; medical plasters and wound dressings ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
[ Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for treating respiratory conditions; Medical inhalers for therapeutic use sold empty ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 035
[ Management, namely, business management, business management planning, business management and advice, business management consultancy services ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
[ Scientific research; Scientific research, namely, conducting clinical trials; Scientific research in the field of pharmaceuticals and clinical trials; Technological services, namely, design and testing for new product development; Technological services, namely, design and testing of new products for others; Industry analysis and research services, namely, pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development, pharmaceutical research services and testing; inspection or research of pharmaceuticals ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
[ Medical services; health care; providing information about health care ]
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010
035
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"